Press Releases
  • April, 09 2014  | Congratulations to Dr. Elizabeth Jaffee on selection to lead Stand Up To Cancer (SU2C)-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team  READ IT HERE
  • April, 08 2014  | Congratulations to Drs. Dung Le and Todd Crocenzi for award of 2014 Pancreatic Cancer Action Network-AACR Research Acceleration Network Grant  READ IT HERE
  • March, 07 2014  | Dirk Brockstedt presents at the 11th Annual International Symposium on Malignant Mesothelioma (first presentation on video, ends at 15:45)  WATCH IT HERE
  • February, 19 2014  | Chief Executive Officer, Stephen Isaacs presents at BIO CEO & Investor Conference (registration required to view video)  WATCH IT HERE
  • February, 10 2014  | Aduro BioTech announces initiation of Phase 2b ECLIPSE trial to evaluate treatment of patients with pancreatic cancer with the company’s innovative immunotherapies  READ IT HERE
  • January, 30 2014  | Aduro announces presentations at the upcoming BIO CEO and Investor Conference and Leerink Global Healthcare Conference  READ IT HERE
  • January, 14 2014  | Aduro announces Phase 2 clinical trial results demonstrating statistically significant survival benefit in pancreatic cancer patients treated with its novel immunotherapies  READ IT HERE
  • January, 14 2014  | Aduro’s Phase 2 trial of GVAX plus CRS-207 is one of five key studies highlighted by ASCO for the 2014 Gastrointestinal Cancers Symposium (please scroll to bottom of press release to open more information on promising vaccine combination)   READ IT HERE

  • Articles
  • February, 20 2014  | Immunotherapy Duo Improves Survival in Metastatic Pancreatic Cancer  READ IT HERE
Copyright 2011-2013 Aduro Biotech. All rights reserved.
Privacy Policy  |  Terms of Use